Dec 1, 2012
Reprint of Epilepsy & Behavior 25 (2012) 631–633. Journal homepage: www.elsevier.com/locate/yebeh Epilepsy and Behavior Editorial Stronger Together   Together The Institute of Medicine (IOM) Report, “Epilepsy...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace, Inc. today announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace® RNS® System, a treatment for adults with partial onset seizures that...
Nov. 14, 2013 – This month, the Epilepsy Foundation and Lundbeck joined together in a nationwide effort to bring information about managing seizures to people living with epilepsy and their families. At the center of the initiative is a new...
Trokendi XR Helps Partial Onset and Seizures Associated with Lennox-Gastaut Syndrome The Food & Drug Administration has issued final approval for Trokendi XR, an extended-release oral formulation of topiramate for treatment of epilepsy...
DEA Delays Threaten to Hurt People Living with Seizures The Epilepsy Foundation calls on the Drug Enforcement Administration (DEA) to revise its process for reviewing new treatments. The current method dampens innovation and lacks transparency...

Pages